Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (278)
- COVID-19 (163)
- Safety monitoring and information (101)
- Legislation (95)
- Compliance and enforcement (70)
- Manufacturing (55)
- Vaping hub (54)
- Labelling and packaging (37)
- Import and export (28)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Weight loss products (15)
- Shortages and supply disruptions (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1264 result(s) found, displaying 576 to 600
-
News articlesThe TGA has now approved an application from the sponsor for an extension of shelf-life to 18 months when stored at 2°C to 8°C.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesCheckMe Pty Ltd fined $13,320 for unlawful import of COVID-19 test kits
-
Media releasesG1 Resources Pty Ltd fined for alleged unlawful importation and advertising of unapproved rapid antigen tests
-
Media releasesCat Media Pty Ltd fined $39,960 for allegedly advertising unregistered Fatblaster weight-loss products
-
Media releasesDentist fined $5,328 for alleged unlawful importation of botox
-
Media releasesThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use as a booster in individuals aged 12 to 15 years old.
-
Media releasesThe TGA has issued an infringement notice of $13,320 for alleged breaches of therapeutic goods legislation in relation to pharmacovigilance.
-
Media releasesThe TGA has issued an infringement notice of $13,320 for alleged breaches of therapeutic goods legislation in relation to pharmacovigilance.
-
Media releasesThe TGA has received an application from GlaxoSmithKline (GSK) Australia Pty Ltd for a higher (1000 mg) dose of its COVID‑19 treatment, sotrovimab (XEVUDY)
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Regulatory decision noticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2022.
-
Media releasesTransition to the mandatory statement requirements of the 2021 Advertising Code
-
Media releasesShen Neng Herbal Medicines Group Pty Ltd fined $53,280 for alleged breaches of therapeutic goods legislation.
-
Regulatory decision noticesSix monthly report – supply of unapproved therapeutic goods by a sponsor.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
-
Media releasesThe TGA has issued an infringement notice for $13,320 to Vaxine Pty Ltd of Adelaide for advertising an unapproved COVID-19 vaccine in alleged breach of the Therapeutic Goods Act 1989.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Regulatory decision noticesPrevention notice under section 42DKB of the Therapeutic Goods Act 1989.
-
Media releasesTGA, part of the Department of Health, has granted a second provisional determination to Biocelect Pty Ltd (on behalf of Novavax Inc.) in relation to its COVID-19 vaccine, Nuvaxovid.
-
Media releasesThe TGA has issued an infringement notice of $13,320 to Getafix Café Pty Ltd (the company) for an alleged breach of the Therapeutic Goods Act 1989 in relation to the advertising of a COVID-19 rapid antigen test on its website.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.